SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 19.52
-0.23 (-1.16%)
Feb 12, 2026, 3:57 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 51.19 million as of February 12, 2026. Its market cap has increased by 24.48% in one year.
Market Cap
51.19M
Enterprise Value
47.40M
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.52
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 51.19M, an increase of 225.43%. That is a compound annual growth rate of 14.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 51.19M | 25.59% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 92.74M |
| 4basebio | 91.32M |
| Faron Pharmaceuticals Oy | 66.58M |
| hVIVO | 60.21M |
| Hemogenyx Pharmaceuticals | 57.75M |
| Ondine Biomedical | 41.09M |
| Poolbeg Pharma | 32.43M |
| ImmuPharma | 31.72M |